Literature DB >> 26723765

Retrograde Approach in Balloon Pulmonary Angioplasty: Useful Novel Strategy for Chronic Total Occlusion Lesions in Pulmonary Arteries.

Takashi Kawakami1, Masaharu Kataoka2, Takahide Arai2, Ryo Yanagisawa2, Yuichiro Maekawa2, Keiichi Fukuda2.   

Abstract

Entities:  

Keywords:  balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; chronic total occlusion; retrograde approach

Mesh：

Year:  2015        PMID： 26723765     DOI： 10.1016/j.jcin.2015.10.031

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  5 in total

1.  Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty.

Authors:  Makoto Takei; Takashi Kawakami; Masaharu Kataoka; Ichiro Kuwahira; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2018-11-20       Impact factor: 2.037

2.  Preprocedural frailty is strongly associated with symptoms after balloon pulmonary angioplasty.

Authors:  Nobutaka Ikeda; Raisuke Iijima; Hidehiko Hara; Yukio Hiroi; Masato Nakamura
Journal:  Glob Health Med       Date:  2022-02-28

3.  Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience.

Authors:  Vidhu Anand; Robert P Frantz; Hilary DuBrock; Garvan C Kane; Michael Krowka; Ryoji Yanagisawa; Gurpreet S Sandhu
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-08-23

4.  Successful depiction of systemic collateral supply to pulmonary artery in CTEPH using time-resolved 4D CT angiography: a case report.

Authors:  Masashi Tamura; Takashi Kawakami; Yoshitake Yamada; Masaharu Kataoka; Seishi Nakatsuka; Keiichi Fukuda; Masahiro Jinzaki
Journal:  Pulm Circ       Date:  2020-04-16       Impact factor: 3.017

5.  Impact and safety of balloon pulmonary angioplasty for elderly patients.

Authors:  Taito Nagai; Nobutaka Ikeda; Raisuke Iijima; Hidehiko Hara; Masato Nakamura
Journal:  Pulm Circ       Date:  2022-01-03       Impact factor: 2.886
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.